The current situation of transcatheter aortic valve replacement in China 2017_West China Medical Journal

Authors：

PAN Wenzhi , ZHOU Daxin ,  GE Junbo

Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai 200032, P. R. China;

Corresponding author：

GE Junbo, Email: ge.junbo2@zs-hospital.sh.cn

Keywords：

Transcatheter aortic valve replacement; Aortic stenosis; Domestic prostheses

DOI：

10.7507/1002-0179.201711135

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Transcatheter aortic valve replacement (TAVR) as a mature technology has been widely applied in Western countries. In China, with the first two domestic prostheses being approved for commercial use, the technology now is expecting a fast development. In this article, we reviewed the features of Chinese aortic stenosis patients, the early Chinese experience of TAVR, the application of domestic prostheses and remaining problems.

Citation： PAN Wenzhi, ZHOU Daxin, GE Junbo. The current situation of transcatheter aortic valve replacement in China 2017. West China Medical Journal, 2018, 33(2): 132-136. doi: 10.7507/1002-0179.201711135 Copy

1.	Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart disease: a report of the American College of Cardiology/American Heart Association Task Force On Clinical Practice Guidelines. J Am Coll Cardiol, 2017, 70(2): 252-289.
2.	Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American college of cardiology/American heart association task force on practice guidelines. Circulation, 2014, 129(23): E521-E643.
3.	Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J, 2017, 38(36): 2739-2791.
4.	Thourani VH, Kodali S, Makkar RR, et al. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity socre analysis. Lancet, 2016, 387(10034): 2218-2225.
5.	顾明标, 白元, 宗刚军, 等. 带瓣膜主动脉瓣支架的研制及体外经导管植入实验. 第二军医大学学报, 2009, 30(2): 117-119.
6.	宋艳斌, 蔡菁, 孙伟, 等. 经导管人工生物主动脉瓣膜置换动物实验. 南京医科大学学报: 自然科学版, 2011, 31(8): 1097-1100, 1147.
7.	葛均波, 周达新, 潘文志, 等. 经皮主动脉瓣植入术一例及其操作要点. 中国介入心脏病学杂志, 2010, 18(5): 243-246.
8.	雍伟哲. 国家心血管病中心首次成功经导管置入国产主动脉瓣装置——我国国产经导管置入主动脉瓣装置临床试验正式启动. 中华医学信息导报, 2012, 27(19): 5.
9.	Jilaihawi H, Wu Y, Yang Y, et al. Morphological characteristics of severe aortic stenosis in China: imaging corelab observations from the first Chinese transcatheter aortic valve trial. Catheter Cardiovasc Interv, 2015, 85(Suppl 1): 752-761.
10.	Pan W, Zhou D, Cheng L, et al. Aortic regurgitation is more prevalent than aortic stenosis in Chinese elderly population: implications for transcatheter aortic valve replacement. Int J Cardiol, 2015, 201: 547-548.
11.	白一帆. 成人心脏瓣膜病外科治疗20年回顾及危险因素变迁. 上海: 第二军医大学, 2012.
12.	曹翔. 成人主动脉瓣置换术后在院死亡危险因素分析. 上海: 第二军医大学, 2012.
13.	潘文志, 周达新, 张蕾, 等. 经颈动脉途径行经导管主动脉瓣置入术一例. 中华心血管病杂志, 2016, 44(4): 348-349.
14.	Liu XB, Jiang JB, Zhou Qj, et al. Evaluation of the safety and efficacy of transcatheter aortic valve implantation in patients with a severe stenoticbicuspid aortic valve in a Chinese population. J Zhejiang Univ Sci B, 2015, 16(3): 208-214.
15.	Xiong TY, Zheng MX, Wei X, et al. Hemodynamic changes after transcatheter aortic valve implantation during sequential follow-ups in patients with bicuspid aortic valve compared with tricuspid aortic valve. Cardiol J, 2017, 24(4): 350-357.
16.	中国医师协会心血管内科医师分会结构性心脏病专业委员会, 中华医学会心血管病学分会结构性心脏病学组. 经导管主动脉瓣置换术中国专家共识. 中国介入心脏病学杂志, 2015, 23(12): 661-667.
17.	Jilaihawi H, Chen M, Webb J, et al. A bicuspid aortic valve imaging classification for the TAVR era. JACC Cardiovasc Imaging, 2016, 9(10): 1145-1158.
18.	Wei L, Liu H, Zhu L, et al. A new transcatheter aortic valve replacement system for predominant aortic regurgitation implantation of the J-Valve and early outcome. JACC Cardiovasc Interv, 2015, 8(14): 1831-1841.
19.	刘庆荣, 吕守良, 吴永健. 国产Venus A-Valve人工主动脉瓣膜的设计特点. 中国医刊, 2015, 50(1): 9-10.
20.	Pan W, Zhou D, Cheng L, et al. Candidates for transcatheter aortic valve implantation may be fewer in China. Int J Cardiol, 2013, 168(5): e133-e134.
21.	潘文志, 周达新, 葛均波. 经导管主动脉瓣置换术在外科手术中、低危患者中的研究现状及展望. 中国介入心脏病学杂志, 2016, 2(24): 107-109.

1. Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart disease: a report of the American College of Cardiology/American Heart Association Task Force On Clinical Practice Guidelines. J Am Coll Cardiol, 2017, 70(2): 252-289.
2. Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American college of cardiology/American heart association task force on practice guidelines. Circulation, 2014, 129(23): E521-E643.
3. Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J, 2017, 38(36): 2739-2791.
4. Thourani VH, Kodali S, Makkar RR, et al. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity socre analysis. Lancet, 2016, 387(10034): 2218-2225.
5. 顾明标, 白元, 宗刚军, 等. 带瓣膜主动脉瓣支架的研制及体外经导管植入实验. 第二军医大学学报, 2009, 30(2): 117-119.
6. 宋艳斌, 蔡菁, 孙伟, 等. 经导管人工生物主动脉瓣膜置换动物实验. 南京医科大学学报: 自然科学版, 2011, 31(8): 1097-1100, 1147.
7. 葛均波, 周达新, 潘文志, 等. 经皮主动脉瓣植入术一例及其操作要点. 中国介入心脏病学杂志, 2010, 18(5): 243-246.
8. 雍伟哲. 国家心血管病中心首次成功经导管置入国产主动脉瓣装置——我国国产经导管置入主动脉瓣装置临床试验正式启动. 中华医学信息导报, 2012, 27(19): 5.
9. Jilaihawi H, Wu Y, Yang Y, et al. Morphological characteristics of severe aortic stenosis in China: imaging corelab observations from the first Chinese transcatheter aortic valve trial. Catheter Cardiovasc Interv, 2015, 85(Suppl 1): 752-761.
10. Pan W, Zhou D, Cheng L, et al. Aortic regurgitation is more prevalent than aortic stenosis in Chinese elderly population: implications for transcatheter aortic valve replacement. Int J Cardiol, 2015, 201: 547-548.
11. 白一帆. 成人心脏瓣膜病外科治疗20年回顾及危险因素变迁. 上海: 第二军医大学, 2012.
12. 曹翔. 成人主动脉瓣置换术后在院死亡危险因素分析. 上海: 第二军医大学, 2012.
13. 潘文志, 周达新, 张蕾, 等. 经颈动脉途径行经导管主动脉瓣置入术一例. 中华心血管病杂志, 2016, 44(4): 348-349.
14. Liu XB, Jiang JB, Zhou Qj, et al. Evaluation of the safety and efficacy of transcatheter aortic valve implantation in patients with a severe stenoticbicuspid aortic valve in a Chinese population. J Zhejiang Univ Sci B, 2015, 16(3): 208-214.
15. Xiong TY, Zheng MX, Wei X, et al. Hemodynamic changes after transcatheter aortic valve implantation during sequential follow-ups in patients with bicuspid aortic valve compared with tricuspid aortic valve. Cardiol J, 2017, 24(4): 350-357.
16. 中国医师协会心血管内科医师分会结构性心脏病专业委员会, 中华医学会心血管病学分会结构性心脏病学组. 经导管主动脉瓣置换术中国专家共识. 中国介入心脏病学杂志, 2015, 23(12): 661-667.
17. Jilaihawi H, Chen M, Webb J, et al. A bicuspid aortic valve imaging classification for the TAVR era. JACC Cardiovasc Imaging, 2016, 9(10): 1145-1158.
18. Wei L, Liu H, Zhu L, et al. A new transcatheter aortic valve replacement system for predominant aortic regurgitation implantation of the J-Valve and early outcome. JACC Cardiovasc Interv, 2015, 8(14): 1831-1841.
19. 刘庆荣, 吕守良, 吴永健. 国产Venus A-Valve人工主动脉瓣膜的设计特点. 中国医刊, 2015, 50(1): 9-10.
20. Pan W, Zhou D, Cheng L, et al. Candidates for transcatheter aortic valve implantation may be fewer in China. Int J Cardiol, 2013, 168(5): e133-e134.
21. 潘文志, 周达新, 葛均波. 经导管主动脉瓣置换术在外科手术中、低危患者中的研究现状及展望. 中国介入心脏病学杂志, 2016, 2(24): 107-109.

Previous Article
Current status of valvular heart disease in China
Next Article
Heart team construction and operation in transcatheter aortic valve replacement

West China Medical Journal

The current situation of transcatheter aortic valve replacement in China 2017

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content